These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1558804)

  • 1. Prolactin and total lactogenic hormone measured by microbioassay and immunoassay in breast cancer.
    Maddox PR; Jones DL; Mansel RE
    Br J Cancer; 1992 Mar; 65(3):456-60. PubMed ID: 1558804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum prolactin and growth hormone determined by radioimmunoassay and a two-site immunoradiometric assay: comparison with the Nb2 cell bioassay.
    Rose DP; Berke B; Cohen LA
    Horm Metab Res; 1988 Jan; 20(1):49-53. PubMed ID: 3371857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioactive and immunoactive prolactin levels after TRH-stimulation in the sera of normal women.
    Maddox PR; Jones DL; Mansel RE
    Horm Metab Res; 1992 Apr; 24(4):181-4. PubMed ID: 1601394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basal prolactin and total lactogenic hormone levels by microbioassay and immunoassay in normal human sera.
    Maddox PR; Jones DL; Mansel RE
    Acta Endocrinol (Copenh); 1991 Dec; 125(6):621-7. PubMed ID: 1789057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of big, big prolactin in patients with hyperprolactinaemia.
    Leite V; Cosby H; Sobrinho LG; Fresnoza MA; Santos MA; Friesen HG
    Clin Endocrinol (Oxf); 1992 Oct; 37(4):365-72. PubMed ID: 1483294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated bioactive prolactin levels in systemic lupus erythematosus--association with disease activity.
    Pacilio M; Migliaresi S; Meli R; Ambrosone L; Bigliardo B; Di Carlo R
    J Rheumatol; 2001 Oct; 28(10):2216-21. PubMed ID: 11669159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated growth hormone levels in sera from breast cancer patients.
    Emerman JT; Leahy M; Gout PW; Bruchovsky N
    Horm Metab Res; 1985 Aug; 17(8):421-4. PubMed ID: 4054832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum bioactive lactogenic hormone levels in women with familial breast cancer and their relatives.
    Anderson E; Morten H; Wang DY; Burns P; Birch J; Howell A
    Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1719-25. PubMed ID: 2632255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new microbioassay for the measurement of lactogenic hormones in human serum.
    Maddox PR; Jones DL; Mansel RE
    Horm Res; 1989; 32(5-6):218-23. PubMed ID: 2634615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin as a local growth promoter in patients with breast cancer: GCRI experience.
    Bhatavdekar JM; Patel DD; Shah NG; Vora HH; Suthar TP; Ghosh N; Chikhlikar PR; Trivedi TI
    Eur J Surg Oncol; 2000 Sep; 26(6):540-7. PubMed ID: 11034803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum prolactin in uraemia: correlations between bioactivity and activity in two immunoassays.
    Smith CR; Butler J; Iggo N; Norman MR
    Acta Endocrinol (Copenh); 1989 Mar; 120(3):295-300. PubMed ID: 2929235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a low-fat diet on hormone levels in women with cystic breast disease. II. Serum radioimmunoassayable prolactin and growth hormone and bioactive lactogenic hormones.
    Rose DP; Cohen LA; Berke B; Boyar AP
    J Natl Cancer Inst; 1987 Apr; 78(4):627-31. PubMed ID: 3470539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum immunoreactive and bioactive lactogenic hormones in advanced breast cancer patients treated with bromocriptine and octreotide.
    Anderson E; Ferguson JE; Morten H; Shalet SM; Robinson EL; Howell A
    Eur J Cancer; 1993; 29A(2):209-17. PubMed ID: 8422285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of new homologous in vitro bioassays for human lactogens to assess the actual bioactivity of human prolactin isoforms in hyperprolactinaemic patients.
    Leaños-Miranda A; Cárdenas-Mondragón G; Rivera-Leaños R; Ulloa-Aguirre A; Goffin V
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):146-53. PubMed ID: 16886952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Euprolactinemic Galactorrhea. Response of bioassayable prolactin to thyrotropin-releasing hormone.
    Ataya KM; Subramanian MG; Lawson DM; Gala RR
    J Reprod Med; 1996 Mar; 41(3):156-60. PubMed ID: 8778412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of serum and breast duct fluid-immunoassayable prolactin and growth hormone with bioassayable lactogenic hormones in healthy women and patients with cystic breast disease.
    Rose DP; Berke B; Cohen LA; Lahti H
    Cancer; 1987 Dec; 60(11):2761-5. PubMed ID: 3119186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum interleukin 2 (IL-2) levels and prolactin bioactive/radioimmunoassay ratios of women at risk for breast cancer.
    Gala RR; Martino S; Wiejowski SA; Kresge CL; Alonso MM
    Eur J Cancer Clin Oncol; 1989 Nov; 25(11):1603-5. PubMed ID: 2591452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HER2 expression in breast cancer: correlation with endocrine function and psychological status in operable and metastatic breast cancer.
    Lissoni P; Messina G; Rovelli F; Brivio F; Fumagalli L; Villa S; Bartolacelli E
    In Vivo; 2009; 23(6):987-9. PubMed ID: 20023245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of tamoxifen on plasma growth hormone and prolactin in postmenopausal women with advanced breast cancer.
    Paterson AG; Turkes A; Groom GV; Webster DJ
    Eur J Cancer Clin Oncol; 1983 Jul; 19(7):919-22. PubMed ID: 6684048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of anti-prolactin autoantibodies on serum prolactin measurements.
    Hattori N; Ikekubo K; Ishihara T; Moridera K; Hino M; Kurahachi H
    Eur J Endocrinol; 1994 May; 130(5):434-7. PubMed ID: 8180668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.